Tianzhihang (688277.SH) issued an announcement that the company plans to jointly fund the establishment with 3 other investors in the form of currency...
Zhitong Finance App News, Tianzhihang (688277.SH) announced that the company plans to jointly fund the establishment of Beijing Ruihuachen Medical Technology Co., Ltd. in monetary form with 3 other investors (the proposed name is subject to the name approved by the Industrial and Commercial Registration Department). The registered capital of the joint venture is RMB 307.70 million, of which Tianzhihang has pledged an investment of RMB 10.00 million, accounting for 32.50%.
The company said that the company and Smart Medicine Technology, a wholly-owned subsidiary of Starry Sky Radiotherapy, and other domestic strategic investors, Mizuki Dongfang and Henganchun Science and Trade jointly initiated the establishment of a joint venture with the aim of introducing advanced international technology, providing products and services based in China, giving full play to the potential and supply chain efficiency advantages of the Chinese market, better promoting the business development of invested projects, and at the same time strengthening in-depth cooperation between the company and invested projects to achieve technical, supply chain, global clinical resources and channel collaboration.
After the establishment of the joint venture, it will establish complete corporate functions such as technology research and development teams, manufacturing bases, marketing, and service in China, share technology research and development results with Starry Sky Radiotherapy America, introduce advanced international technology, and provide products and services to the world based in China.